| Literature DB >> 30923622 |
Joosu Kuivanen1,2, Veera Korja1, Sami Holmström1,3, Peter Richard1.
Abstract
BACKGROUND: The CRISPR/Cas9 is currently the predominant technology to enhance the genome editing efficiency in eukaryotes. Established tools for many fungal species exist while most of them are based on in vivo expressed Cas9 and guide RNA (gRNA). Alternatively, in vitro assembled Cas9 and gRNA ribonucleoprotein complexes can be used in genome editing, however, only a few examples have been reported in fungi. In general, high-throughput compatible transformation workflows for filamentous fungi are immature.Entities:
Keywords: Aspergillus niger; Automation; CRISPR; Galactarate; Galacturonate; Genome editing; High-throughput; Metabolic engineering; Mucic acid; Pectin
Year: 2019 PMID: 30923622 PMCID: PMC6419801 DOI: 10.1186/s40694-019-0066-9
Source DB: PubMed Journal: Fungal Biol Biotechnol ISSN: 2054-3085
Fig. 1Schematic presentation of the developed microtiter plate scale CRISPR/Cas9 transformation method for A. niger which is based on the transformation of in vitro assembled RNP complex
Fig. 2a CRISPR/Cas9 facilitated deletion of A. niger gaaX gene based on in vitro assembled RNP complex and donor DNA containing pyrG selection marker. Targeting efficiency was analysed by using colony PCR ensuring the absence of gaaX ORF (primers 1, oPEEL-294/295) and the presence of donor DNA cassette at the correct genomic locus (primers 2, oPEEL-279/292 and 3, oPEEL-293/334). Targeting efficiency and the colony forming units (CFU) per 105 protoplasts and 1 µg donor DNA b with 1500 bp flanking sequence in the donor DNA and different concentrations of RNP complex and c with 90 nm RNP complex and varying lengths of flanking sequence in the donor DNA. 3–12 colonies from each transformation depending on colony number on plates were analyzed
Colony forming units (CFU) and deletion efficiencies of the gaaX gene using a liquid handling robot to carry out the transformation
| RNP (nM) | CFU | Colonies screened | Correct |
|---|---|---|---|
| 162 | 25 | 5 | 4 |
| 90 | 28 | 3 | 2 |
| 54 | 15 | 2 | 1 |
| 18 | 10 | 4 | 2 |
| 9 | 13 | 6 | 2 |
| 0 | 6 | 5 | 1 |
Fig. 3Schematic presentation of the a workflow and b target genes for multiplexed A. niger genome editing using the microtiter plate scale CRISPR/Cas9 method. The workflow was demonstrated by engineering the fungal d-galacturonate pathway for galactarate (mucic acid) production. The competing pathway genes gaaA, encoding a d-galacturonate reductase, gaaC, encoding an l-galactonate dehydratase, and 39114, encoding an enzyme involved in galactarate catabolism, and gaaX, encoding a repressor protein of pectin catabolic pathways, were deleted by replacing the genes with DNA cassettes expressing the bacterial uronate dehydrogenase (UDH)
Efficiencies of correct replacements of target genes with the UDH expression cassette in multiplexed CRISPR/Cas9 using RNP complexes
| Target genes | gRNA | Colonies screened | Correct | Correct | Correct | All correct | Targeting efficiency (%) |
|---|---|---|---|---|---|---|---|
|
| gERA-009 | 2 | 2 | – | – | 2 | 100 |
| gERA-010 | 5 | 5 | – | – | 5 | 100 | |
| gERA-009 + gERA-010 | 5 | 5 | – | – | 5 | 100 | |
| gERA-009 + gERA-015 | 4 | 3 | 1 | – | 1 | 25 | |
| gERA-010 + gERA-016 | 7 | 1 | 2 | – | 0 | 0 | |
| gERA-009 + gERA-015+ | 8 | 1 | 3 | – | 1 | 13 | |
| gERA-010 + gERA-016 | |||||||
| gERA-001 + gERA-009 + gERA-015 | 6 | 3 | 1 | 2 | 0 | 0 | |
| gERA-002 + gERA-010 + gERA-016 | 6 | 1 | 1 | 4 | 1 | 17 | |
| gERA-001 + gERA-009 + gERA-015 + gERA-002 + gERA-010 + gERA-016 | 5 | 2 | 2 | 2 | 0 | 0 |
Two different crRNAs for each of the target genes were designed and tested in different combinations
Fig. 4Production of galactarate from a 20 g l−1 pectin and b 20 g l−1 d-galacturonate with the engineered A. niger strains generated using the multiplexed microtiter plate scale CRISPR/Cas9 genome editing method. The engineered strains resulting from multiplexed (blue squares and yellow circles) and single target (red diamonds) CRISPR genome editing were cultivated on YP medium supplemented with 20 g l−1 pectin or d-galacturonate. The galactarate producing strain from the previous study [16] (grey triangles) was used as a control strain. Values represent the means of three biological replicates ± SD